Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Parsons

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Stroke and Vascular Neurology|January 29, 2024
Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trialXin Cheng, Lan Hong, Leonid Churilov, et al.
Plos One|March 24, 2016
Agricultural Management and Climatic Change Are the Major Drivers of Biodiversity Change in the UKFiona Burns, Mark A Eaton, Kate E Barlow, et al.
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
BMJ Neurology Open|January 23, 2023
Door-in-door-out times for patients with large vessel occlusion ischaemic stroke being transferred for endovascular thrombectomy: a Victorian state-wide studyJoseph Zhi Wen Wong, Helen M Dewey, Bruce C V Campbell, et al.
Gigascience|September 29, 2020
An extensible big data software architecture managing a research resource of real-world clinical radiology data linked to other health data from the whole Scottish populationThomas Nind, James Sutherland, Gordon McAllister, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Annals of Neurology|February 20, 2022
Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT StudiesAmrou Sarraj, Mark Parsons, Andrew Bivard, et al.
Stroke|January 2, 2025
Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical TrialXin Cheng, Lan Hong, Longting Lin, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Stroke and Vascular Neurology|January 29, 2024
Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trialXin Cheng, Lan Hong, Leonid Churilov, et al.
Plos One|March 24, 2016
Agricultural Management and Climatic Change Are the Major Drivers of Biodiversity Change in the UKFiona Burns, Mark A Eaton, Kate E Barlow, et al.
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
BMJ Neurology Open|January 23, 2023
Door-in-door-out times for patients with large vessel occlusion ischaemic stroke being transferred for endovascular thrombectomy: a Victorian state-wide studyJoseph Zhi Wen Wong, Helen M Dewey, Bruce C V Campbell, et al.
Gigascience|September 29, 2020
An extensible big data software architecture managing a research resource of real-world clinical radiology data linked to other health data from the whole Scottish populationThomas Nind, James Sutherland, Gordon McAllister, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Annals of Neurology|February 20, 2022
Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the EXTEND-IA Trials, INSPIRE, and SELECT StudiesAmrou Sarraj, Mark Parsons, Andrew Bivard, et al.
Stroke|January 2, 2025
Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical TrialXin Cheng, Lan Hong, Longting Lin, et al.
Pageof 18